Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Dr. Antonella Santuccione Chadha, Women` s Brain Foundation,  Switzerland.

Dr. Antonella Chadha Santuccione is a highly accomplished clinical pathologist, neuroscientist, and executive leader with notable expertise in clinical trial management and cognitive behavioral therapy. Born in Italy and based in Switzerland, she has held executive roles and board memberships across biotech and healthcare organizations. She is also the founder and pro-bono CEO of the Women’s Brain Foundation, emphasizing her commitment to neuroscience and gender-specific brain health.

Profile

Scopus
Orcid

📚 Early Academic Pursuits

Dr. Antonella Chadha Santuccione’s academic foundation is deeply rooted in medical science and behavioral therapy, reflecting her passion for understanding the human mind and body. Born on June 13, 1974, in Penne, Italy, she pursued her education in medicine, earning her MD with specialization in Clinical Pathology. Furthering her academic rigor, she attained credentials from FMH and MEBEKO and completed a CAS in Clinical Trial Management. With an eye toward holistic care and human psychology, she expanded her studies to include Cognitive Behavioral Therapy. Her diverse training laid the groundwork for a multifaceted approach to clinical neuroscience, bridging biology, diagnostics, and therapeutic psychology.

🧪 Professional Endeavors

Throughout her professional journey, Dr. Santuccione has combined her clinical acumen with entrepreneurial vision. After relocating to Switzerland, she took on advisory roles in several neuro-focused start-ups including Bottneuro, Altoida, Pipra, ReconnectLab, and EqualCare, where she played a pivotal role in aligning scientific discovery with patient-centered innovation. Serving as an Executive Director and Board Member across multiple initiatives, she brought together cross-disciplinary teams to push the frontiers of diagnostics and digital health. Her pro-bono leadership as the Founder and CEO of the Women’s Brain Foundation further demonstrates her commitment to addressing gender disparities in brain health research and care.

🧠 Contributions and Research Focus

Dr. Santuccione’s work focuses on the intersection of neuroscience, gender-specific medicine, and clinical innovation. Her research advocacy highlights the importance of considering sex differences in neurodegenerative diseases such as Alzheimer’s, a field historically underexplored. By promoting personalized approaches to brain health, she has helped shape how researchers and clinicians think about prevention, diagnosis, and treatment across genders. Her insights into cognitive decline, early diagnostic markers, and patient-centric treatment frameworks have influenced both academic thought and clinical practice. Additionally, her work in start-ups integrates AI and data-driven technologies to monitor cognitive health, marking her as a forerunner in digital neuroscience.

🏅 Accolades and Recognition

Dr. Santuccione’s contributions have earned her widespread acclaim both within Switzerland and internationally. She was selected among the Top 100 Business Women in Switzerland from 2018 to 2023, a testament to her sustained influence in science and innovation. In 2019, she was named Woman of the Year by Women in Business CH through a public election, highlighting her societal impact beyond the scientific community. The World Sustainability Award in 2020 and the Bold Women Award Switzerland in 2022 recognized her efforts in building ethical, inclusive scientific models. Most recently, she received the Empowering Women Award 2024 and was featured among the Women to Watch 2025, celebrating her as a role model for future leaders.

🌍 Impact and Influence

Beyond her clinical and scientific achievements, Dr. Santuccione has become a global advocate for change in the healthcare landscape. Her work challenges the traditional silos of medicine, psychology, and technology, offering integrative solutions that are ethical and inclusive. She has empowered countless women in STEM through her foundation, speaking engagements, and mentorship programs. Her influence extends into public policy discussions and public health awareness campaigns, where she brings attention to the need for gender equity and individualized treatment in brain disorders. She is not only a scientist but a communicator who bridges science and society.

💡 Legacy and Future Contributions

Dr. Antonella Chadha Santuccione is a trailblazer shaping the next era of neuroscience through compassion-driven research and visionary leadership. Her legacy lies in her determination to dismantle systemic barriers in medicine—especially those that affect women—and in creating frameworks where innovation serves the individual. With ongoing roles in biotech leadership, nonprofit work, and public advocacy, she is set to further influence global conversations around brain health, mental wellness, and gendered research. Her career is a beacon for aspiring researchers who believe that science should serve humanity with empathy, precision, and equity.

🧬 A Champion for Brain Science and Humanity

Dr. Santuccione embodies the rare synthesis of scientific brilliance, leadership excellence, and humanitarian vision. Her work underscores a commitment to better understanding the human brain—not only through the lens of pathology, but also through the lens of experience, gender, and empathy. As she continues her journey, she stands as a symbol of what it means to be a 21st-century neuroscientist: grounded in evidence, driven by innovation, and devoted to people.

Publication

1. Title: Women’s brain health and brain capital
Authors: Laura Castro-Aldrete, Megan Greenfield, Erin Smith, Harris A. Eyre, Mariapaola Barbato, Lucy Pérez, Antonella Santuccione Chadha
Year: 2025

2. Title: Abortion and Miscarriage on Twitter: Sentiment and Polarity Analysis from a gendered perspective
Authors: Olivier Philippe, María Flores Rodero, Claire Yohalem Furtick, Laura Planas Simón, Maria Teresa Ferretti, Antonella Santuccione Chadha, Laia Subirats Maté, Davide Cirillo, María José Rementeria
Year: 2024

3. Title: Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts
Authors: Matamoros-Angles A, Mohammadi B, Song F, Shafiq M, Brenna S, Puig B, Glatzel M, Altmeppen HC
Year: 2023

4. Title: Global synergistic actions to improve brain health for human development
Authors: Owolabi MO, Leonardi M, Bassetti C, Jaarsma J, Hawrot T, Makanjuola AI, Dhamija RK, Feng W, Straub V, Camaradou J, et al.
Year: 2023

5. Title: Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution
Authors: Laura Castro-Aldrete, Moser MV, Putignano G, Ferretti MT, Schumacher Dimech A, Antonella Santuccione Chadha
Year: 2023

6. Title: Towards AI-driven longevity research: An overview
Authors: Marino N, Putignano G, Cappilli S, Chersoni E, Antonella Santuccione Chadha, Calabrese G, Bischof E, Vanhaelen Q, Zhavoronkov A, Scarano B
Year: 2023

7. Title: Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
Authors: Pfundstein G, Nikonenko AG, Sytnyk V
Year: 2022

8. Title: Prions induce an early Arc response and a subsequent reduction in mGluR5 in the hippocampus
Authors: Ojeda-Juárez D, Lawrence JA, Soldau K, Pizzo DP, Wheeler E, Aguilar-Calvo P, Khuu H, Chen J, Malik A, Funk G, et al.
Year: 2022

9. Title: Digital biomarkers and sex impacts in Alzheimer’s disease management – potential utility for innovative 3P medicine approach
Authors: Harms RL, Ferrari A, Meier IB, Martinkova J, Santus E, Marino N, Cirillo D, Mellino S, Catuara Solarz S, Tarnanas I, et al.
Year: 2022

🏁 Conclusion

Dr. Antonella Chadha Santuccione’s career is a model of interdisciplinary excellence, innovation, and advocacy. Her ability to blend neuroscience research with executive leadership and public engagement sets her apart as a visionary in brain health. She not only advances the scientific understanding of neurodegeneration but also actively reshapes how gender and equity are addressed in medical research. With a lasting legacy in both scientific and humanitarian domains, she is exceptionally well-suited for high-level recognition such as the Best Researcher Award and remains a powerful voice shaping the future of neuroscience globally.

 

Jørgen Slots | Clinical Neuroscience |

Posted on by Neuroscientists

Prof. Dr. Jørgen Slots | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Jørgen Slots, University of Southern California,  United States.

Dr. Jørgen Slots is an internationally recognized scholar in periodontology and oral microbiology, with a rich academic and professional background rooted in Denmark, the United States, and Sweden. After completing multiple advanced degrees—including a D.D.S., Ph.D., D.M.D., and M.B.A.—he held tenured and leadership roles at esteemed institutions such as the Royal Dental College, SUNYAB, and the University of Göteborg. His research focused on microbial causes of periodontal disease, bridging the gap between laboratory science and clinical treatment. Throughout his career, he has been a pioneer in integrating microbiology into dental education and has significantly influenced both teaching and clinical standards globally. His work continues to inform practices in oral health and inspire the next generation of researchers and clinicians.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born in 1944 in Vejle, Denmark, Dr. Jørgen Slots embarked on a lifelong journey in dentistry and biomedical science that began at the prestigious Royal Dental College in Copenhagen. He earned his D.D.S. in 1969 and continued to delve deeper into academic excellence with an M.S. (Lic. Odont.) in 1974. His passion for periodontology led him to complete postgraduate education in this specialty by 1976, setting the stage for a research-intensive career. Not stopping there, he pursued advanced studies in microbiology at the Forsyth Dental Center in Boston, Massachusetts, where he earned a Certificate in Microbiology in 1977. By 1979, he had completed his doctoral thesis (Dr. Odont./Ph.D.), a reflection of his rigorous scientific training and commitment to academic inquiry.

🧪 Professional Endeavors in Dental Science

Dr. Slots’ career spans both private practice and academia, beginning with clinical work in Copenhagen from 1969 to 1976. However, his true calling was in academia and research, where he quickly rose through the ranks at the Royal Dental College, becoming a tenured associate professor in the Department of Periodontology and Bacteriology. His academic influence extended internationally as he moved to the United States, joining the State University of New York at Buffalo (SUNYAB) as a visiting associate professor in 1977. His multifaceted roles there included teaching, research, and graduate mentorship. In 1982, his expertise was recognized with a professorial and chair appointment at the University of Göteborg in Sweden, where he led the Department of Oral Microbiology until 1986.

🔬 Contributions and Research Focus

Dr. Slots’ core research has focused on periodontal microbiology, particularly the microbial etiology of periodontal diseases and the role of anaerobic bacteria in oral infections. His extensive background in both clinical periodontology and microbiology enabled him to bridge these disciplines, pioneering investigations into microbial pathogenesis, host responses, and antimicrobial therapy. His work at the intersection of dentistry and microbiology has contributed significantly to the understanding of how bacterial biofilms influence periodontal health and disease progression. Through his positions in leading institutions, he has mentored countless students and young researchers in translational oral biology.

🏅 Accolades and Recognition

Throughout his distinguished career, Dr. Slots has earned numerous accolades that acknowledge both his scholarly achievements and teaching excellence. His academic journey includes obtaining a D.M.D. from the University of Pennsylvania in 1986, further consolidating his clinical credentials. In 1989, he expanded his skillset by earning an M.B.A. from the Wharton School, indicating his interest in healthcare administration and leadership. Such accomplishments reflect a rare blend of scientific acumen, clinical expertise, and administrative insight that is seldom seen in one individual. His tenured appointments and leadership roles speak volumes about the respect he commands in his field.

🌍 Impact and Global Influence

Dr. Slots’ contributions have had global implications, influencing not only North American dental education but also shaping European periodontal research. His tenure at institutions in Denmark, Sweden, and the United States illustrates his international standing and thought leadership. By combining laboratory science with clinical application, he has contributed to international standards in oral hygiene practices, periodontal disease diagnostics, and treatment protocols. His collaborative work across continents has helped create a robust, evidence-based approach to periodontal care that is taught and practiced worldwide.

📚 Legacy in Dental Education and Microbiology

As a graduate faculty member and department chair, Dr. Slots played a vital role in curriculum development, graduate training, and interdisciplinary integration of oral microbiology into mainstream dental education. He has influenced a generation of oral biologists and periodontists who continue to build upon his foundational work. His teaching style, grounded in research and clinical relevance, made him a beloved educator and mentor. The ripple effects of his academic stewardship can still be seen in the progressive research and pedagogical models employed at the University of Southern California and other leading dental institutions.

🔭 Future Vision and Continuing Relevance

Though his primary academic career has matured, the legacy of Dr. Slots remains very much alive in ongoing research studies, collaborative clinical trials, and academic dialogues. His integration of clinical practice with microbiological research stands as a model for future dental scientists aiming to address emerging challenges in oral-systemic health. With a unique blend of intellectual rigor and compassionate mentorship, Dr. Slots has laid a foundation that will support future breakthroughs in both academic and applied dental sciences. His life’s work continues to inspire innovation and scientific inquiry in oral health worldwide.

Publication

Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions
A Ashimoto, C Chen, I Bakker, J Slots – 1996

Subgingival microflora and periodontal disease
J Slots – 1979

Periodontitis: facts, fallacies and the future
J Slots – 2017

Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival
J Slots, RJ Genco – 1984

Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases
J Slots, MA Listgarten – 1988

Selective medium for isolation of Actinobacillus actinomycetemcomitans
J Slots – 1982

Actinobacillus actinomycetemcomitans in Human Periodontal Disease: a Cross-Sectional Microbiological Investigation
J Slots, HS Reynolds, RJ Genco – 1980

Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases
ILC Chapple, R Genco, Working Group 2 of the Joint EFP/AAP Workshop – 2013

The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults
J Slots, L Bragd, M Wikström, G Dahlén – 1986

Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment
J Slots, M Ting – 1999

Antibiotics in periodontal therapy: advantages and disadvantages
J Slots, TE Rams – 1990

The predominant cultivable microflora of advanced periodontitis
J Slots – 1977

Actinobacillus actinomycetemcomitans in Human Periodontal Disease: Prevalence in Patient Groups and Distribution of Biotypes and Serotypes Within Families
JJ Zambon, LA Christersson, J Slots – 1983

Systemic antibiotic therapy in periodontics
AJV Winkelhoff, TE Rams, J Slots – 1996

Microbial differences in 2 clinically distinct types of failures of osseointegrated implants
ES Rosenberg, JP Torosian, J Slots – 1991

The predominant cultivable organisms in juvenile periodontitis
J Slots – 1976

Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline
J Slots, BG Rosling – 1983

Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy
J Slots, P Mashimo, MJ Levine, RJ Genco – 1979

Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease
JJ Zambon, J Slots, RJ Genco – 1983

🏁 Conclusion

Dr. Jørgen Slots’ career stands as a remarkable example of interdisciplinary excellence in dental science. Through his research in periodontal microbiology, leadership in academic institutions, and dedication to global dental education, he has left a lasting legacy. His contributions have not only advanced scientific knowledge but also improved clinical approaches to oral healthcare worldwide. Dr. Slots remains a towering figure whose impact resonates in the fields of periodontology, microbiology, and beyond.

Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Dr.  Liliana Elena Weimer, Center For Global Health Istituto Superiore di Sanita’ Rome, Italy.

Dr. Liliana Elena Weimer is a highly accomplished physician and clinical researcher , where she has risen to the prestigious Level II “First Researcher” position. Her professional focus lies in clinical trials for infectious diseases, particularly HIV and Hepatitis C. She has played a critical role in major national and international research efforts, including collaborations with the U.S. Clinical Trials Group and leadership of the large-scale PITER cohort involving 25,000 HCV patients. She is known not only for her scientific contributions but also for her humanitarian efforts during the COVID-19 emergency. Among her recognitions is the 1st Prize at the 2019 International Congress on Hepatitis C in Seville. Throughout her career, she has exemplified scientific integrity, dedication, and service to public health.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born on December 19, 1965, in Buenos Aires to Italian parents, Dr. Liliana Elena Weimer embraced her dual heritage and committed herself to a life in medicine and research. With Italian citizenship and deep academic determination, she laid the groundwork for her career by studying medicine, ultimately finding her professional home in Italy. Her academic path, though not fully detailed, clearly led her toward a focus on clinical medicine and infectious diseases, with her earliest professional roles marking the beginning of a lifelong engagement in public health and biomedical research. Her intellectual dedication and international roots later became an asset in global research collaborations.

🩺 Professional Endeavors

Dr. Weimer’s distinguished career spans over three decades at the Italian National Institute of Health (ISS), beginning in 1985. Starting as a dedicated clinical physician, she ascended to Level III researcher status by 1990 and continued to grow into higher ranks, culminating in her success in the national Art. 15 competition for the Level II “First Researcher” role in 2022, officially backdated to 2021. Throughout her tenure at ISS, she became a central figure within the Global Health Center in Rome. Known for her tireless commitment, she often described her career not simply as a job but as a “mission,” emphasizing both her personal and professional passion for making a difference in human health.

🧪 Contributions and Research Focus

Specializing in clinical trials, Dr. Weimer has coordinated and participated in numerous groundbreaking studies in HIV and Hepatitis C (HCV). Since the early 1990s, she has collaborated closely with renowned figures such as Prof. Giovanni Rossi, Prof. Stefano Vella, and Prof. Gianni Rezza, contributing to some of the most pivotal HIV antiretroviral therapy trials in history. Her research efforts extended to co-leading and organizing both national and international multicenter clinical trials. Notably, she has been at the forefront of the PITER study, a major nationwide cohort that follows 25,000 patients undergoing HCV treatment—one of the most comprehensive initiatives in Italy in the fight against hepatitis.

🌍 Global Collaborations and Humanitarian Engagement

Her impact extends beyond Italy, thanks to her active involvement with the U.S.-based American Clinical Trials Group on HIV studies. These collaborations have enhanced international understanding and treatment of HIV/AIDS. In addition to her clinical and research commitments, Dr. Weimer also devoted herself to frontline service during the COVID-19 pandemic. Volunteering both with the Civil Protection unit and at Bambino Gesù Children’s Hospital, she demonstrated profound humanitarian values. Her presence during a critical time underscored her belief in serving communities not just from behind a lab desk but also on the ground, directly supporting patients and health systems under strain.

🏅 Accolades and Recognition

Dr. Weimer’s work has been acknowledged at both national and international levels. One of the most prominent recognitions she received was the 1st Prize at the International Congress on Hepatitis C held in Seville in November 2019, a testament to her excellence and influence in the field of infectious disease research. Her achievements are not only measured in accolades but also in the tangible difference her work has made in advancing therapy options and clinical management of chronic viral diseases. Her rise within the ISS and the trust placed in her leadership of major research projects further affirm her standing within the scientific community.

💡 Impact and Influence

Over the course of her extensive career, Dr. Weimer has significantly shaped clinical research strategies in Italy, especially regarding chronic viral infections. Her coordination of thousands of patient cases within structured clinical trials has informed policy decisions and improved treatment protocols nationwide. Her presence at the ISS has also influenced future generations of researchers and clinicians, many of whom benefited from her mentorship, leadership, and example of scientific integrity. Through her rigorous methods and patient-focused approach, she has played a key role in Italy’s standing as a leader in global health research, especially in relation to HIV and HCV.

🔬 Legacy and Future Contributions

Looking forward, Dr. Weimer’s contributions will continue to echo through the fields of virology and clinical medicine. Her involvement in the PITER cohort and other studies has laid down essential groundwork for long-term epidemiological surveillance and patient care strategies. With her appointment as First Researcher, she enters a new chapter of leadership, likely to drive more innovative, patient-centered research initiatives in global health. Her legacy lies not only in her publications or awards but also in the thousands of lives improved by the treatments she helped to test, refine, and implement. The combination of scientific rigor and heartfelt service defines her enduring contribution to modern medicine.

Publication

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C – TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, … – 2010

 

  • Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‐year follow‐up of 150 patients – SL George, BR Bacon, EM Brunt, KL Mihindukulasuriya, J Hoffmann, … – 2009

 

  • Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis – V Saxena, L Nyberg, M Pauly, A Dasgupta, A Nyberg, B Piasecki, … – 2015

 

  • Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy – D Persaud, SC Ray, J Kajdas, A Ahonkhai, GK Siberry, K Ferguson, … – 2007

 

  • Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real‐world cohort study – EB Tapper, BR Bacon, MP Curry, DT Dieterich, SL Flamm, LE Guest, … – 2016

 

  • Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA – S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, … – 2009

 

  • Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study – R Mellado-Artigas, LE Mujica, ML Ruiz, BL Ferreyro, F Angriman, E Arruti, … – 2021

 

  • A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients – M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, … – 1999

 

  • Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort – LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, … – 2017

 

  • Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER network – LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, … – 2017

 

🏁 Conclusion

Dr. Weimer stands as a distinguished figure in the field of global health research, with deep expertise in clinical trials and infectious diseases. Her legacy is marked by landmark contributions to HIV and HCV treatment protocols, influential collaborations, and compassionate public service. Her ongoing work continues to shape public health policy and medical research in Italy and beyond. As she advances in her leadership role at the ISS, her experience, insight, and dedication will remain vital to future innovations in clinical research and global health.

Baoman Li | Neuroanatomy | Best Researcher Award

Posted on by Neuroscientists

Prof. Baoman Li | Neuroanatomy | Best Researcher Award

Prof. Baoman Li, China Medical University,  China.

Professor Baoman Li stands at the forefront of contemporary neuroscience and pharmacology, merging deep academic knowledge with impactful translational research. From his foundational training at China Medical University to his postdoctoral work in the United States, he has consistently demonstrated excellence in exploring the physiological and molecular mechanisms of the central nervous system. Currently a Professor and Department Director, his work has revealed novel insights into cerebrospinal fluid transport, neuronal excitability regulation, and bipolar disorder modeling. These discoveries have been featured in top-tier journals such as PNAS, Cell Metabolism, and Molecular Psychiatry.

Profile

Scopus

🎓 Early Academic Pursuits

Baoman Li’s journey into the world of biomedical science began with a strong academic foundation. He pursued his Ph.D. in Medical Pharmacology at China Medical University, where he cultivated a keen interest in the intersection of neuroscience, pharmacology, and toxicology. His early research provided him with an in-depth understanding of neural mechanisms and laid the groundwork for his future innovations. Eager to expand his international experience, he furthered his postdoctoral research at the University of Rochester Medical Center (USA) from 2013 to 2014, where he deepened his expertise in neuropharmacological research.

🧪 Professional Endeavors

Currently serving as a Professor and Department Director at the Forensic Analytical Toxicology Department of China Medical University, Professor Li leads a dynamic team of researchers and scholars. His leadership has not only enhanced academic standards within the department but has also positioned it as a center of excellence in the field of neuroglial research and forensic toxicology. His multidisciplinary approach merges analytical science with neuroscience, significantly advancing our understanding of central nervous system (CNS) function and dysfunction.

🧠 Contributions and Research Focus

Professor Li’s research focuses on cutting-edge discoveries related to neural mechanisms, cerebrospinal fluid dynamics, and neuropsychiatric disorders. One of his landmark studies, published in PNAS (2024), identified ependymal cell-mediated cerebrospinal fluid transport from the CNS to peripheral organs, revealing a critical physiological communication pathway. In another pivotal contribution in Cell Metabolism (2025), he elucidated the role of the NE-FFA-Na⁺/K⁺-ATPase pathway in regulating neuronal hyperexcitability and behavioral arousal. Moreover, his groundbreaking development of a circadian disruption-induced manic mouse model for bipolar disorder research (published in Molecular Psychiatry, 2023) has provided a valuable tool for studying mood disorders and developing new therapeutic approaches.

📚 Academic Publications and Editorial Work

With an impressive academic portfolio, Professor Li has authored and edited three influential books centered on neuroglial science, expanding the literature in this specialized domain. His published works include notable titles with ISBNs: 978-7-117-34321-3, 978-3-030-77375-5, and 978-2-88963-497-2. These contributions serve as essential resources for both emerging and seasoned neuroscientists, offering detailed insights into glial biology, neurochemical interactions, and translational research.

🏅 Accolades and Recognition

Professor Li’s scholarly excellence is widely recognized, as reflected in his H-index of 34 and a total citation count of 3,530 according to Web of Science. His ability to consistently produce high-impact research has made him a respected voice in neuroscience and pharmacology. He has successfully led eight research projects funded by prestigious bodies such as the Natural Science Foundation of China and the Ministry of Education, while also currently heading two additional projects supported by the provincial science foundation.

🤝 Industry and Consultancy Impact

Beyond academic circles, Professor Li has extended his expertise into practical applications through four consultancy projects, bridging the gap between research and real-world forensic or pharmaceutical needs. His ability to translate complex neuropharmacological findings into actionable insights for the industry underscores his role as not only a theorist but also a problem-solver and innovator.

🔬 Legacy and Future Contributions

As a scientist, educator, and leader, Professor Baoman Li continues to shape the future of neuroscience and pharmacological toxicology. His ongoing research and collaborative efforts are expected to yield further breakthroughs in understanding brain-behavior relationships and disease mechanisms. With a legacy already marked by innovation and impact, his future contributions promise to enhance diagnostics, treatments, and preventive strategies for neurological and psychiatric disorders. His commitment to mentoring young scholars and editing academic literature ensures that his influence will resonate across generations of researchers to come.

Publication

  • Title: Cerebrospinal Fluid Enters Peripheral Organs by Spinal Nerves Supporting Brain–Body Volume Transmission
    Authors: Li, Baoman; Xia, Maosheng; Harkany, Tibor; Verkhratsky, Alexei N.
    Year: Not specified (likely 2024 or 2025)

 

  • Title: Anti-seizure effects of norepinephrine-induced free fatty acid release
    Authors: Li, Baoman; Sun, Qian; Ding, Fengfei; Smith, Nathan A.; Nedergaard, Maiken
    Year: 2025
    Journal: Cell Metabolism

 

  • Title: Major depressive disorder: hypothesis, mechanism, prevention and treatment
    Authors: Cui, Lulu; Li, Shu; Wang, Siman; Xia, Maosheng; Li, Baoman
    Year: Not specified (likely 2024 or 2025)
    Type: Review (Open access)

 

  • Title: The periaxonal space as a conduit for cerebrospinal fluid flow to peripheral organs
    Authors: Li, Xinyu; Wang, Siman; Zhang, Dianjun; Xia, Maosheng; Li, Baoman
    Year: 2024
    Journal: Proceedings of the National Academy of Sciences of the USA (Open access)

 

  • Title: Dexmedetomidine improves the circulatory dysfunction of the glymphatic system induced by sevoflurane through the PI3K/AKT/ΔFosB/AQP4 pathway in young mice
    Authors: Wang, Shuying; Yu, Xiaojin; Cheng, Lili; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Cell Death and Disease (Open access)

 

  • Title: Ketamine administration causes cognitive impairment by destroying the circulation function of the glymphatic system
    Authors: Wu, Xue; Wen, Gehua; Yan, Lei; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Biomedicine and Pharmacotherapy (Open access)

 

  • Title: Correction to: Ketamine Improves the Glymphatic Pathway by Reducing the Pyroptosis of Hippocampal Astrocytes in the Chronic Unpredictable Mild Stress Model
    Authors: Wen, Gehua; Zhan, Xiaoni; Xu, Xiaoming; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Molecular Neurobiology (Erratum, Open access)

 

  • Title: Ketamine Improves the Glymphatic Pathway by Reducing the Pyroptosis of Hippocampal Astrocytes in the Chronic Unpredictable Mild Stress Model
    Authors: Wen, Gehua; Zhan, Xiaoni; Xu, Xiaoming; Lu, Yan; Wu, Xu
    Year: 2024
    Journal: Molecular Neurobiology

 

  • Title: Trace metals and astrocytes physiology and pathophysiology
    Authors: Li, Baoman; Yu, Weiyang; Verkhratsky, Alexei N.
    Year: 2024
    Journal: Cell Calcium

 

Conclusion:

Dr. Baoman Li is a strong and deserving candidate for the Best Researcher Award. His innovative research, publication in high-impact journals, and interdisciplinary contributions demonstrate excellence and sustained scientific productivity. While he can enhance his visibility and further define his leadership role, his current achievements are more than sufficient to merit this prestigious recognition.

 

Abdullah Alghamdi | Emerging Areas in Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Mr. Abdullah Alghamdi | Emerging Areas in Neuroscience | Best Researcher Award

Mr. Abdullah Alghamdi, University of Birmingham (UK) and Taibah University (Saudi Arabia),  United Kingdom.

Eng. Abdullah A. Zohaid (SMIEEE, SMIET) is an accomplished electrical engineer and academic with a specialization in Smart Power Systems, focusing on electric vehicles, AI-integrated transportation systems, and sustainable smart city infrastructure. With a solid educational foundation—earning distinctions at every academic level—he has seamlessly merged academic excellence with real-world engineering experience. From his early career at Saudi Aramco to his dual lecturing roles at Taibah University and the University of Birmingham, Abdullah has built a reputation as a forward-thinking researcher, educator, and strategist. His work bridges technical innovation with societal needs, aiming to optimize power grids and energy systems for a sustainable future.

Profile

Google Scholar

🎓 Early Academic Pursuits

From the historic city of Medina, Saudi Arabia, Eng. Abdullah A. Zohaid embarked on his academic journey in Electrical Engineering at Taibah University, where his talent and determination earned him distinction in his final project. His academic passion soon carried him to the United Kingdom, where he pursued an MSc in Electrical Power Systems at the University of Birmingham, graduating with First-Class Honors and distinction. Abdullah’s unwavering commitment to academic excellence continued as he embarked on a Ph.D. in Smart Power Systems at the same institution. Excelling in all areas, he has distinguished himself through both research prowess and scholastic achievement.

⚡ Professional Endeavors

Eng. Alghamdi has established himself as a dynamic professional straddling the worlds of academia and industry. His journey began with Saudi Aramco’s Dodsal Company, contributing to the vital 56″ Gas Pipeline project as an assistant electrical engineer. He transitioned into academia with his role as a Lecturer at Taibah University in Yanbu and later joined the University of Birmingham as a faculty member. Balancing dual academic roles in Saudi Arabia and the UK, Abdullah has developed a unique global perspective, blending practical engineering insight with cutting-edge educational delivery. His presence as an educator underscores his belief in empowering future engineers with real-world readiness.

🔬 Contributions and Research Focus

A scholar deeply embedded in the future of sustainable power, Eng. Alghamdi’s research focuses on Smart Power Systems, electric vehicles, smart charging infrastructures, and the integration of AI in intelligent transportation systems. Through his ongoing Ph.D. research, he explores how emerging technologies can enhance smart grid resilience and contribute to the development of smart cities. He utilizes advanced simulation and optimization tools such as MATLAB/SIMULINK, Python, and Gurobi, combined with machine learning techniques (ANN/CNN), to propose innovative solutions that address pressing energy challenges. His passion for sustainability is evident in his contributions to the global energy discourse, especially in urban mobility and decarbonization.

🏆 Accolades and Recognition

Eng. Zohaid’s career is adorned with recognition and academic milestones. His consistent distinction in every academic phase, including honors during both his MSc and Ph.D. studies, reflects a sustained trajectory of excellence. As a senior member of prestigious engineering bodies like IEEE and IET, and a certified Professional Engineer by the Saudi Council of Engineers, his credentials are a testament to his standing in the professional community. Furthermore, his publications in Q1 journals and contributions to leading international conferences validate the depth of his research and the quality of his scholarly communication.

🌍 Impact and Influence

With affiliations across IEEE working groups and university research circles, Eng. Alghamdi’s influence spans global academic and professional spheres. As a presenter and contributor at numerous high-level conferences — from the IEEE Power & Energy Society to Net Zero Futures and Saudi Innovation events — he has played a key role in shaping conversations on smart energy. His multidisciplinary expertise allows him to drive collaborations across AI, optimization, and power systems, impacting both policy and practice. His ability to simplify complex engineering concepts and communicate them effectively has enabled him to become a trusted voice among peers and students alike.

💡 Innovation and Strategic Vision

Abdullah’s strength lies in visionary thinking and strategic problem-solving. He doesn’t merely research problems—he crafts systems and strategies that reflect future-forward thinking. His approach to sustainable urban infrastructure blends technological acumen with strategic planning, leadership, and innovation. As an educator and researcher, he fosters environments that promote critical thinking and team-based innovation, cultivating the next generation of engineers equipped to face tomorrow’s challenges. His work on smart charging and intelligent transportation embodies the essence of transformative impact through design thinking and systems innovation.

🚀 Legacy and Future Contributions

Looking ahead, Eng. Abdullah A. Zohaid is poised to leave a lasting legacy in the realm of smart power systems and urban sustainability. His dual role as a lecturer and researcher gives him a powerful platform to shape both academic knowledge and real-world applications. With his continued focus on electrification, smart mobility, and AI-driven infrastructure, he is on track to influence policy, inspire innovation, and expand the boundaries of what is possible in modern power systems. His legacy will be defined not only by the technologies he helps build but also by the students and professionals he inspires along the way.

Publication

  • Innovative Prepositioning and Dispatching Schemes of Electric Vehicles for Smart Distribution Network Resiliency and Restoration
    AAM Alghamdi, D. Jayaweera, 2022

 

  • Resilience of Modern Power Distribution Networks with Active Coordination of EVs and Smart Restoration
    AAM Alghamdi, D. Jayaweera, 2023

 

  • Modelling Frameworks Applied in Smart Distribution Network Resiliency and Restoration
    AAM Alghamdi, D. Jayaweera, 2022

 

  • Resilience-Oriented Restoration in Modern Power Distribution Networks with Smart Electric Vehicles Coordination Framework
    A. Alghamdi, D. Jayaweera, 2023

 

  • Risk and Resilience Based Residential Electric Vehicle Integration Framework for Restoration of Modern Power Distribution Networks
    A. Alghamdi, D. Jayaweera, 2025

 

  • Electric Boats and Electric Vehicles Data-Driven Approach for Enhanced Resilience in Power Distribution Networks
    AAM Alghamdi, D. Jayaweera, 2025

 

✅ Conclusion

Eng. Alghamdi stands at the forefront of energy transformation, using research, innovation, and teaching as tools to drive meaningful change. His contributions reflect a blend of technical mastery and visionary leadership, enabling progress in smart mobility, clean energy, and intelligent infrastructure. With a growing portfolio of Q1 publications, prestigious memberships, and impactful conference roles, he continues to influence the field of electrical engineering on a global scale. As he advances in his career, his legacy will be marked by both technological advancements and the future minds he mentors—solidifying his role as a transformative figure in the evolution of smart power systems.

Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng, Wake Forest University School of Medicine, United States.

Dr. Che Ping Cheng, M.D., Ph.D., FAHA, is a distinguished cardiovascular physiologist and internal medicine specialist whose career has been dedicated to advancing the understanding of heart function and failure. From earning his medical degree in China to completing a Ph.D. in Physiology at Wayne State University, and later conducting pivotal postdoctoral research at Wake Forest School of Medicine, Dr. Cheng has consistently pursued excellence in science and education. His research on ventricular mechanics, volume loading, and heart failure has significantly influenced both experimental cardiology and clinical practice. Recognized as a Fellow of the American Heart Association, he is also a dedicated mentor, shaping the next generation of cardiovascular researchers through his academic leadership.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Che Ping Cheng’s journey into medicine and science began in Nanjing, China, where he earned his M.D. degree from Nanjing Railway Medical University in 1977. His early academic path reflected a deep interest in understanding the intricacies of human health, particularly in cardiovascular physiology. Driven by a desire to expand his knowledge and research capabilities, Dr. Cheng pursued his Ph.D. in Physiology at Wayne State University School of Medicine in Detroit, Michigan, completing his degree in 1986. Under the mentorship of Dr. Robert S. Shepard, his doctoral work focused on exploring the mechanisms of cardiovascular response to volume loading in a canine model with tricuspid valvulectomy, setting a strong foundation for his lifelong focus on heart function and disease mechanisms.

🩺 Professional Endeavors

Following his academic training, Dr. Cheng embarked on postdoctoral studies at the Bowman Gray School of Medicine (now part of Wake Forest School of Medicine), where he continued to cultivate his expertise in internal medicine and cardiovascular physiology. Between 1986 and 1988, he served as a Postdoctoral Fellow under the guidance of Dr. William C. Little. His research during this period focused on ventricular dynamics and the physiological factors affecting active ventricular filling, which would later inform his broader work on heart failure and cardiac function. Dr. Cheng has since remained at Wake Forest School of Medicine, where he is currently a distinguished member of the Section on Cardiovascular Medicine.

🧪 Contributions and Research Focus

Dr. Cheng’s career has been characterized by a deep commitment to advancing the understanding of cardiac hemodynamics, ventricular interaction, and heart failure mechanisms. His research has explored how ventricular function responds under altered physiological states, and how these responses inform disease progression and treatment strategies. His early animal model studies have provided critical insights into the interplay between structural and functional changes in the heart, especially in the context of diastolic dysfunction and volume overload conditions. Dr. Cheng has also made significant strides in translating these findings to clinical contexts, influencing how cardiologists approach diagnosis and therapy.

🏅 Accolades and Recognition

Throughout his career, Dr. Cheng has received considerable recognition for his scholarly contributions. He is a Fellow of the American Heart Association (FAHA), an honor that reflects his standing in the field of cardiovascular research and his commitment to scientific excellence. His work has earned the respect of colleagues and institutions alike, leading to numerous invitations to contribute to collaborative projects, serve on peer-review panels, and mentor future generations of cardiovascular researchers.

🌍 Impact and Influence

Dr. Cheng’s work has had a lasting impact on both experimental and clinical cardiology. By elucidating the mechanistic basis of ventricular dysfunction, he has helped shift paradigms in heart failure management, particularly in the areas of ventricular interdependence and preload responsiveness. His research findings are frequently cited in textbooks and high-impact journals, and they continue to inform guidelines for cardiac care and interventions. Through his work at Wake Forest and beyond, Dr. Cheng has played a pivotal role in bridging laboratory discoveries with bedside applications.

👨‍🏫 Legacy and Mentorship

As a respected mentor and educator, Dr. Cheng has dedicated a significant portion of his career to training medical students, residents, and postdoctoral fellows. His mentorship has influenced numerous emerging scholars in cardiovascular medicine, many of whom have gone on to successful academic and clinical careers. His guidance combines a rigorous scientific approach with a deep sense of responsibility to patient care and scientific integrity, shaping a legacy that extends well beyond his own research output.

🔬 Future Contributions and Vision

Looking ahead, Dr. Cheng remains committed to the advancement of cardiovascular research, with a continued focus on uncovering the cellular and mechanical determinants of heart disease. His vision includes fostering collaborative projects that integrate biomedical engineering, imaging, and computational modeling to further understand cardiac performance. With decades of experience and a forward-thinking approach, Dr. Cheng’s future contributions are poised to leave a lasting mark on the field of translational cardiovascular medicine.

Publication

  1. Title: Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
    Authors: Sun, Xiaoqiang; Cao, Jing; Chen, Zhe; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2023
    Journal: Heliyon

 

  1. Title: Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
    Authors: Mikhailov, Alexei V.; Liu, Yixi; Cheng, Hengjie; Lin, Jen Jar; Cheng, Cheping
    Year: 2022
    Journal: Heliyon

 

  1. Title: Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms
    Authors: Zhang, Xiaowei; Li, Tiankai; Cheng, Hengjie; Groban, Leanne; Cheng, Cheping
    Year: 2021
    Journal: Life Sciences

 

  1. Title: Chronic Ca2+/calmodulin-dependent protein Kinase II inhibition rescues advanced heart failure
    Authors: Liu, Yixi; Shao, Qun; Cheng, Hengjie; Zhao, David Xiao Ming; Cheng, Cheping
    Year: 2021
    Journal: Journal of Pharmacology and Experimental Therapeutics

 

  1. Title: The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
    Authors: Ferrario, Carlos M.; Groban, Leanne; Wang, Hao; Sun, Xuming; Ahmad, Sarfaraz
    Year: 2021
    Journal: Molecular and Cellular Endocrinology

 

  1. Title: Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
    Authors: Li, Tiankai; Zhang, Zhi; Zhang, Xiaowei; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2020
    Journal: International Journal of Cardiology

 

  1. Title: Female Heart Health: Is GPER the Missing Link?
    Authors: Groban, Leanne; Tran, Q. K.; Ferrario, Carlos M.; Wang, Hao; Lindsey, Sarah H.
    Year: (Not specified, but likely 2020 or 2021)
    Journal: (Not specified)

 

🏁 Conclusion

Dr. Cheng’s legacy is one of intellectual rigor, clinical relevance, and mentorship. His work has not only deepened the scientific understanding of cardiac physiology but has also shaped modern approaches to diagnosing and managing heart failure. With a career spanning continents and disciplines, Dr. Cheng continues to be a guiding force in cardiovascular medicine, and his future contributions are anticipated to further advance the frontiers of heart research and patient care.

 

Chen Shoubin | Behavioral Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Dr. Chen Shoubin | Behavioral Neuroscience | Best Researcher Award

Dr. Chen Shoubin, Shenzhen University,  China.

Dr. Shoubin Chen is a forward-thinking Research Fellow at the Guangdong Laboratory of Artificial Intelligence and Digital Economy (Shenzhen), affiliated with Shenzhen University. With a Ph.D. in Photogrammetry and Remote Sensing, his career has been rooted in the intersection of spatial intelligence, robotics, and AI. From leading national research projects to publishing in reputable journals and securing multiple invention patents, Dr. Chen has made substantial contributions to the field of embodied intelligent robotics. His research emphasizes multi-sensor fusion and autonomous mapping, aiming to give machines human-like spatial perception and decision-making capabilities.

Profile

Google Scholar

 

📚 Early Academic Pursuits

Shoubin Chen’s academic journey began with a strong foundation in geospatial sciences, culminating in a Ph.D. in Photogrammetry and Remote Sensing in 2020. This prestigious degree was awarded through a rigorous joint training program between Wuhan University and the Finnish Geospatial Research Institute. During his doctoral studies, he developed a deep interest in integrating advanced spatial data techniques with artificial intelligence, laying the groundwork for his future research endeavors. His early academic phase was marked by a commitment to cross-border scientific collaboration and multidisciplinary exploration, which has since defined his research approach.

🧑‍💻 Professional Endeavors

Currently serving as a Research Fellow and graduate supervisor at the Guangdong Laboratory of Artificial Intelligence and Digital Economy (Shenzhen) and Shenzhen University, Dr. Chen plays a pivotal role in advancing embodied intelligence within the Spatial Intelligence Team. His responsibilities include mentoring postgraduate students, overseeing cutting-edge research, and steering major national and provincial scientific projects. He has contributed to several national-level initiatives, including two National Natural Science Foundation of China grants, support from the China Postdoctoral Science Foundation, and sub-projects under the National Key Research and Development Program. These experiences have sharpened his expertise in high-precision robotic mapping and autonomous navigation.

🤖 Contributions and Research Focus

Dr. Chen’s primary research focus lies in embodied intelligent robotics, with an emphasis on multi-sensor fusion, robotic perception, and spatial mapping technologies. He is recognized for integrating data from various sensing modalities to improve the autonomy and spatial awareness of robotic systems. His innovations aim to empower robots with human-like spatial understanding, allowing them to operate reliably in complex environments. This research direction is crucial for applications ranging from autonomous vehicles to intelligent service robots, contributing significantly to the frontier of AI-driven robotics.

🏅 Accolades and Recognition

Throughout his academic and professional career, Shoubin Chen has garnered considerable recognition for his scientific excellence. He has published nearly ten high-quality papers as either the first or corresponding author in SCI Q2 journals and CCF B-tier or higher conferences and journals. Moreover, he has applied for over ten invention patents, underscoring his commitment to both theoretical advancement and practical application. His reputation in the academic community is further highlighted by his service as a peer reviewer for prestigious platforms such as the IEEE Internet of Things Journal, Remote Sensing of Environment, IEEE Transactions on Intelligent Vehicles, and ICRA, one of the top robotics conferences globally.

🌐 Impact and Influence

Dr. Chen’s work has had a profound impact on the fields of AI, robotics, and spatial computing. His multi-disciplinary approach has influenced how robots understand and interact with their environments, offering transformative possibilities in smart cities, autonomous transport, and digital mapping. By fusing photogrammetry with robotics and AI, he has contributed to a new paradigm in spatial intelligence that bridges digital perception and physical action. His projects have not only generated academic outputs but have also driven technological innovations with potential for real-world deployment.

🌱 Legacy and Future Contributions

As a mentor, innovator, and research leader, Shoubin Chen continues to inspire the next generation of scientists and engineers in AI and robotics. His forward-looking vision involves deepening the integration of embodied intelligence with environmental understanding, enabling machines to collaborate more intuitively with humans. He is poised to expand his research to include human-robot interaction, sustainable urban intelligence, and smart sensing systems. With a growing portfolio of publications, patents, and mentorship experiences, his contributions are set to leave a lasting legacy in the development of intelligent systems that seamlessly bridge perception and action.

🔬 Vision in Artificial Intelligence and Robotics

Guided by a vision that combines spatial science with artificial cognition, Dr. Chen’s work embodies the future of AI-powered robotics. His pursuit of intelligent, context-aware robotic systems aligns with global goals in automation, smart infrastructure, and digital economy. As AI becomes increasingly pervasive in everyday life, his contributions are steering the technology toward safer, more efficient, and more interactive systems. Through continuous innovation and collaboration, he remains at the forefront of a transformative research frontier that blends engineering precision with visionary thinking.

Publication

  • Title: Exploring embodied multimodal large models: Development, datasets, and future directions
    Authors: S Chen, Z Wu, K Zhang, C Li, B Zhang, F Ma, FR Yu, Q Li
    Year: 2025

 

  • Title: Distributed Robust Communication-Efficient Multi-Robot SLAM Combining Real-Time Intersection and Historical Loop Constraints
    Authors: B Zhang, Z Xiong, J Qiu, S Chen, Y Hu, S Chen
    Year: 2025

 

  • Title: TextGeo-SLAM: A LiDAR SLAM With Text Semantics and Geometric Constraints-Based Loop Closure
    Authors: S Chen, C Li, Q Jiang, X Zhuang, B Zhang, B Zhou, Q Li
    Year: 2024

 

  • Title: ASL-SLAM: A LiDAR SLAM with activity semantics-based loop closure
    Authors: B Zhou, C Li, S Chen, D Xie, M Yu, Q Li
    Year: 2023

 

  • Title: Comparative analysis of SLAM algorithms for mechanical LiDAR and solid-state LiDAR
    Authors: B Zhou, D Xie, S Chen, H Mo, C Li, Q Li
    Year: 2023

 

  • Title: Research on SLAM based on LiDAR/visual fusion (LV-SLAM)
    Authors: C Shoubin
    Year: 2023

 

  • Title: Cooperative smartphone GNSS/PDR for pedestrian navigation
    Authors: C Jiang, Y Chen, C Chen, S Chen, Q Meng, Y Bo, J Hyyppa
    Year: 2022

 

  • Title: Indoor Attitude Estimation Using Equipped Gyroscopes and Depth Sensors
    Authors: Q Shi, Z Song, Z Xiao, S Chen, F Wang
    Year: 2022

 

  • Title: LI-SLAM: Fusing LiDAR and Infrared Camera for Simultaneous Localization and Mapping
    Authors: B Zhou, D Xie, S Chen, C Li, H Mo
    Year: 2022

 

  • Title: NDT-LOAM: A real-time LiDAR odometry and mapping with weighted NDT and LFA
    Authors: S Chen, H Ma, C Jiang, B Zhou, W Xue, Z Xiao, Q Li
    Year: 2021

 

✅ Conclusion

In conclusion, Dr. Shoubin Chen exhibits all the core qualities of a Best Researcher Award recipient: deep scientific insight, proven research leadership, strong publication and patent output, and a visionary approach to solving real-world problems through AI and robotics. While there are opportunities to grow his international footprint, his current accomplishments already place him among the leading young researchers in his field. Based on the evidence of impact, innovation, and research excellence, he is highly suitable for the Best Researcher Award.

Atena Shojaie | Behavioral Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Ms. Atena Shojaie | Behavioral Neuroscience | Best Researcher Award

Ms. Atena Shojaie, Kerman university of medical sciences, Iran.

Atena Shojaie is a dedicated medical-surgical nursing professional with a Master’s degree from Kerman University of Medical Sciences. Her early academic journey was marked by a passion for integrating clinical care with research, particularly in neurology and rehabilitation. Over three years of working in critical care settings, including Neurology and ICU wards, she honed her clinical expertise while also serving as a valued clinical instructor. Her research focus on guided imagery as a therapeutic intervention for multiple sclerosis and MRI-induced anxiety has led to innovative practices currently in use at major hospitals. Atena’s academic contributions are beginning to gain recognition through citations and clinical adoption of her methods.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Atena Shojaie began her journey in the field of healthcare with a strong academic foundation, earning a bachelor’s degree in nursing followed by a Master of Science in Medical-Surgical Nursing from Kerman University of Medical Sciences. Her early academic interests revolved around holistic patient care and neuro-rehabilitation, which laid the groundwork for her later clinical and research endeavors. During her postgraduate studies, she demonstrated a deep commitment to understanding patient needs—especially those facing neurological challenges—while also refining her clinical skills in hospital environments.

🏥 Professional Endeavors

In the span of just three years, Atena accumulated extensive experience working in several critical hospital wards, including Neurology, Neurosurgery, and the Intensive Care Unit (ICU). Her hands-on experience with acute and chronic conditions shaped her clinical intuition and enhanced her ability to manage complex patient cases. Parallel to her clinical work, she embraced the role of a clinical instructor, mentoring nursing and emergency medical students with a balance of academic rigor and compassionate teaching. This dual role of caregiver and educator reflects her deep-seated dedication to both practice and pedagogy.

🔬 Contributions and Research Focus

Atena’s research primarily centers on the intersection of psychological interventions and physical rehabilitation, with a particular emphasis on multiple sclerosis (MS). Her master’s thesis, “The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis,” stands as a cornerstone of her academic work. The project demonstrated measurable improvements in gait and balance among MS patients and has since influenced ongoing clinical practices. Additionally, she completed a significant study on the “Anxiety of Patients Undergoing Magnetic Resonance Imaging (MRI),” showing how guided imagery can alleviate pre-procedure stress—further reflecting her commitment to patient-centered innovations.

🧠 Innovations in Mental Imagery

Atena Shojaie has been instrumental in translating academic research into practical tools for patient care. One of her notable innovations includes the creation of a guided imagery audio file, which is now regularly used in two major healthcare centers—Bahonar Hospital’s MRI department and Shafa Hospital’s MS Clinic. This therapeutic tool has not only improved the mental well-being of patients but also contributed to smoother clinical workflows, particularly in high-anxiety environments like radiology units.

📈 Impact and Influence

Although still early in her research career, Atena’s work has begun to gain scholarly recognition. With a citation index that includes three citations and an h-index of 1, her research is already laying the foundation for future studies in neuro-nursing and psychological rehabilitation. Her work continues to resonate with clinical teams and academics alike, especially those focused on non-pharmacological interventions for neurological conditions.

🏅 Accolades and Recognition

Atena’s clinical and research activities have earned her respect among her peers and mentors at Kerman University of Medical Sciences. While formal awards may still be on the horizon, her true recognition lies in the adoption of her guided imagery methods by major hospitals—an endorsement of both her scientific rigor and clinical insight. Her role as a trusted clinical instructor further affirms her reputation as a knowledgeable and compassionate professional.

🌟 Legacy and Future Contributions

With a solid foundation in research and hands-on care, Atena Shojaie is poised to make enduring contributions to the field of neuro-rehabilitative nursing. Her vision includes expanding the use of therapeutic mental imagery in broader hospital settings and conducting multi-center studies to further validate its effectiveness. As she continues her academic and clinical journey, her legacy will likely be defined by a thoughtful fusion of science, compassion, and innovation—paving the way for future advancements in holistic patient care.

Publication

 

  • Anxiety of Patients Undergoing Magnetic Resonance Imaging (MRI): The Effectiveness of Guided Mental Imagery
    Authors: A. Shojaie, H. Amiri, T. Dehesh, B. Bagherian
    Year: 2024

 

  • The Effectiveness of Guided Imagery on Walking and Balance Dysfunction in Patients With Multiple Sclerosis: A Randomized Controlled Trial
    Authors: B.B. Atena Shojaie, Hoda Kamali, Monir Sadat Nematollahi, Zahra Imani Goghary
    Year: 2025

 

✅ Conclusion

Atena Shojaie exemplifies the new generation of nurse-researchers who bridge the gap between evidence-based practice and compassionate patient care. Her work in guided mental imagery not only addresses physical dysfunction but also supports patients’ emotional and psychological needs. As she continues to expand her research and clinical impact, Atena is well-positioned to influence future standards in neuro-nursing and non-pharmacological therapy. Her legacy will likely be defined by innovation, empathy, and a relentless pursuit of better outcomes for patients with neurological conditions.

Hao Lai | Clinical Neuroscience | Best Researcher Award

Posted on by Neuroscientists

Prof. Dr. Hao Lai | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Hao Lai, Zhongshan Hospital, Fudan University, China.

Dr. Hao Lai is a distinguished cardiovascular surgeon and researcher, currently serving as Chief Physician at Zhongshan Hospital, Fudan University. With over 20 years of clinical expertise, he specializes in aortic and cardiovascular surgery. His academic achievements include a Ph.D. in Surgery from Fudan University and significant contributions to the study of epigenetic mechanisms in thoracic aortic dissection. As a principal investigator of nationally funded projects and co-author of influential publications, Dr. Lai combines scientific rigor with clinical innovation. He has also played a key role in medical education and device development through industry collaboration.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Hao Lai began his academic journey with a strong foundation in medical sciences, culminating in a Ph.D. in Surgery from the prestigious Fudan University. His early academic pursuits were marked by a deep interest in cardiovascular physiology and surgical intervention, which later matured into a specialized focus on aortic diseases. His time as a doctoral candidate not only equipped him with rigorous scientific training but also ignited his lifelong commitment to solving complex clinical problems through research.

🏥 Professional Endeavors

Currently serving as Chief Physician at Zhongshan Hospital, Fudan University, Dr. Hao Lai has accumulated over two decades of extensive clinical experience in cardiovascular and aortic surgery. His professional trajectory reflects a seamless integration of surgical excellence with academic leadership. At Zhongshan Hospital, a leading institution in China, he has spearheaded several clinical programs aimed at enhancing patient outcomes in cases of thoracic aortic dissection and other high-risk cardiovascular conditions.

🔬 Contributions and Research Focus

Dr. Lai’s research centers around the epigenetic mechanisms underlying thoracic aortic dissection, with a particular focus on histone modification and DNA methylation. He is the Principal Investigator of a major research project funded by the National Natural Science Foundation of China, which explores the role of H3K36me3 histone modification and DNMT3B-mediated gene body methylation in the pathogenesis of aortic dissection. His scientific efforts bridge molecular pathology with clinical implications, offering new perspectives on the diagnosis and treatment of life-threatening vascular disorders.

🏆 Accolades and Recognition

A respected voice in cardiovascular medicine, Dr. Hao Lai has co-authored numerous influential articles in high-impact journals such as Cardiovascular Research and Advanced Science. His h-index of 18, as listed on Scopus, reflects his consistent scholarly output and the wide academic acknowledgment of his work. In addition, his authorship of the textbook Practical Surgery (3rd Edition), published by People’s Medical Publishing House, stands as a testament to his educational contributions to the next generation of Chinese surgeons.

🧪 Impact and Innovation

Dr. Lai’s research has made a tangible impact on the understanding and treatment of aortic diseases. His investigation into the epigenetic regulation of vascular pathology has opened new avenues for targeted therapies. Moreover, his collaboration with MicroPort Endovascular MedTech demonstrates his commitment to translating research findings into real-world applications, particularly in the development and refinement of endovascular surgical devices.

🌍 Influence and Collaboration

Beyond his direct research and surgical contributions, Dr. Lai’s influence extends into collaborative domains, both nationally and internationally. His leadership in high-level research grants, clinical trials, and industrial partnerships positions him as a central figure in the evolving landscape of cardiovascular surgery. His collaborative spirit fosters innovation and promotes cross-disciplinary dialogue, essential in today’s complex medical research environment.

🔮 Legacy and Future Contributions

As Dr. Hao Lai continues his distinguished career, his legacy is being shaped not only by his surgical accomplishments but also by his contributions to medical science. His ongoing projects are likely to further clarify the molecular landscape of aortic diseases and inspire new therapeutic strategies. Looking ahead, Dr. Lai is poised to remain at the forefront of cardiovascular innovation, committed to improving patient care through a synthesis of research, education, and clinical practice.

Publication

 

Title: Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study
Authors: J. Cui, Y. Zhang, Y. Wang, Q. Ji, C. Wang
Year: 2025


Title: A novel open-vascular single-branched stent graft in total arch repair of type A aortic dissection one-year results of a prospective multicenter randomized controlled study
Authors: J. Gu, W. Zhang, L. Kang, H. Lai, C. Wang
Year: 2025


Title: Fibroblast Activation Protein Acts as a Biomarker for Monitoring ECM Remodeling During Aortic Aneurysm via 68Ga-FAPI-04 PET Imaging
Authors: C. Hu, H. Tan, Y. Zhang, X. Chen, L. Wang
Year: 2025


Title: Mitochondrial NAD+ deficiency in vascular smooth muscle impairs collagen III turnover to trigger thoracic and abdominal aortic aneurysm
Authors: J. Zhang, Y. Tang, S. Zhang, K. Zhu, W. Zhang
Year: 2025


Title: Correcting mitochondrial loss mitigates NOTCH1-related aortopathy in mice
Authors: Y. Tang, J. Zhang, Y. Fang, Y. Xu, W. Zhang
Year: 2025


Title: Exploration of 68Ga-FAPI-04 PET/MR in Chronic Type B Aortic Dissection
Authors: C. Hu, Y. Zhang, S. Qiu, H. Shi, L. Wang
Year: 2025


Title: Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: A randomized controlled trial
Authors: M. Luo, J. Luo, X. Xu, G. Tu, Z. Luo
Year: 2024


Title: Therapeutic results of three-dimensional aortic valve anatomic repair for regurgitant bicuspid aortic valve
Authors: J. Li, C. Wang, Z. Zuo, W. Ding, T. Hong
Year: 2024


Title: 68Ga-FAPI-04 Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Ascending Aortic Aneurysm
Authors: C. Hu, H. Tan, Y. Zhang, H. Lai, L. Wang
Year: 2024


Title: Sex-based outcomes after thoracic endovascular aortic repair: A systematic review and meta-analysis
Authors: Y. Zhang, Y. Zhang, Y. Wang, L. Wang, Q. Ji
Year: 2025

✅ Conclusion

Dr. Hao Lai’s career represents a powerful blend of surgical precision, scientific insight, and academic leadership. His work has advanced the understanding of aortic diseases at the molecular level while improving surgical outcomes for patients. As he continues to mentor, innovate, and lead research at the intersection of epigenetics and cardiovascular pathology, Dr. Lai’s contributions are set to leave a lasting legacy in both clinical practice and medical science.